|
🐜
|
Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway.
8 auth.
Jizhong Liu,
A. Hamrouni,
D. Wołowiec,
V. Coiteux,
K. Kuliczkowski,
D. Hétuin,
...
A. Saudemont,
B. Quesnel
|
9 |
2007 |
9
🐜
|
|
🐜
|
Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.
23 auth.
C. Preudhomme,
J. Guilhot,
F. Nicolini,
A. Guerci-Bresler,
F. Rigal-huguet,
F. Maloisel,
V. Coiteux,
M. Gardembas,
C. Berthou,
A. Vekhoff,
...
D. Réa,
E. Jourdan,
C. Allard,
A. Delmer,
P. Rousselot,
L. Legros,
M. Berger,
S. Corm,
G. Étienne,
C. Roche-Lestienne,
V. Eclache,
F. Mahon,
F. Guilhot
|
8 |
2010 |
8
🐜
|
|
🐜
|
Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience.
25 auth.
Sophie Park,
S. Grabar,
C. Kelaidi,
O. Beyne-Rauzy,
F. Picard,
V. Bardet,
V. Coiteux,
G. Leroux,
P. Lepelley,
M. Daniel,
S. Cheze,
B. Mahé,
A. Ferrant,
C. Ravoet,
M. Escoffre-barbe,
...
L. Adès,
N. Vey,
L. Aljassem,
A. Stamatoullas,
L. Mannone,
H. Dombret,
K. Bourgeois,
P. Greenberg,
P. Fenaux,
F. Dreyfus
|
8 |
2008 |
8
🐜
|
|
🐜
|
Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study.
20 auth.
D. Réa,
F. Nicolini,
M. Tulliez,
F. Guilhot,
J. Guilhot,
A. Guerci-Bresler,
M. Gardembas,
V. Coiteux,
G. Guillerm,
L. Legros,
...
G. Étienne,
J. Pignon,
B. Villemagne,
M. Escoffre-barbe,
J. Ianotto,
A. Charbonnier,
H. Johnson-Ansah,
M. Noel,
P. Rousselot,
F. Mahon
|
8 |
2017 |
8
🐜
|
|
🐜
|
Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia.
22 auth.
N. Dhédin,
A. Huynh,
S. Maury,
R. Tabrizi,
K. Beldjord,
V. Asnafi,
X. Thomas,
P. Chevallier,
S. Nguyen,
V. Coiteux,
...
J. Bourhis,
Y. Hichri,
M. Escoffre-barbe,
O. Reman,
C. Graux,
Y. Chalandon,
D. Blaise,
U. Schanz,
V. Lheritier,
J. Cahn,
H. Dombret,
N. Ifrah
|
7 |
2015 |
7
🐜
|
|
🐜
|
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.
21 auth.
S. Botton,
V. Coiteux,
S. Chevret,
C. Rayón,
E. Vilmer,
M. Sanz,
J. Serna,
N. Philippe,
A. Baruchel,
G. Leverger,
...
A. Robert,
J. Miguel,
E. Conde,
J. Sotto,
D. Bordessoule,
N. Fegueux,
M. Fey,
A. Parry,
C. Chomienne,
L. Degos,
P. Fenaux
|
7 |
2004 |
7
🐜
|
|
🐜
|
Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease.
8 auth.
L. Magro,
M. Mohty,
B. Catteau,
V. Coiteux,
P. Chevallier,
L. Terriou,
...
J. Jouet,
I. Yakoub-Agha
|
7 |
2009 |
7
🐜
|
|
🐜
|
Risk factors for candidemia: a prospective matched case-control study
70 auth.
J. Poissy,
Lauro Damonti,
A. Bignon,
N. Khanna,
M. von Kietzell,
K. Boggian,
D. Neofytos,
F. Vuotto,
V. Coiteux,
F. Artru,
S. Zimmerli,
J. Pagani,
T. Calandra,
B. Sendid,
D. Poulain,
...
C. van Delden,
F. Lamoth,
O. Marchetti,
P. Bochud,
J. D. C. P. K. T. A. A. C. P. P. C. D. N. F. O. Aubert Berger Bochud Boggian Calandra Christe Cone,
J. Aubert,
C. Berger,
P. Bochud,
K. Boggian,
T. Calandra,
A. Christe,
A. Conen,
C. Corti-Fragoso,
P. Dutkowski,
P. Eggimann,
C. Garzoni,
D. Goldenberger,
N. Khanna,
F. Lamoth,
O. Marchetti,
E. Maggio,
K. Mühlethaler,
D. Neofytos,
D. Sanglard,
P. Schreiber,
U. Schanz,
C. van Delden,
M. von Kietzell,
R. Zbinden,
S. Zimmerli,
F. A. V. D. A. K. N. T. B. E. E. D. C. E. J. D. S. L. Artru Bignon Coiteux Deblauw El Kalioubie Faure Fr,
F. Artru,
A. Bignon,
V. Coiteux,
D. Deblauw,
A. El Kalioubie,
K. Faure,
N. François,
T. Galpérine,
B. Guery,
E. Jaillette,
Eric Kipnis,
D. Mathieu,
C. Nilès,
E. Parmentier-Decrucq,
J. Poissy,
D. Poulain,
S. Préau,
L. Rahmania,
L. Robriquet,
A. Rouzé,
B. Sendid,
E. Vega,
B. Voisin,
P. Weyrich
|
6 |
2020 |
6
🐜
|
|
🐜
|
Risk factors for candidemia: a prospective matched case-control study
70 auth.
J. Poissy,
Lauro Damonti,
A. Bignon,
N. Khanna,
M. von Kietzell,
K. Boggian,
D. Neofytos,
F. Vuotto,
V. Coiteux,
F. Artru,
S. Zimmerli,
J. Pagani,
T. Calandra,
B. Sendid,
D. Poulain,
...
C. van Delden,
F. Lamoth,
O. Marchetti,
P. Bochud,
J. D. C. P. K. T. A. A. C. P. P. C. D. N. F. O. Aubert Berger Bochud Boggian Calandra Christe Cone,
J. Aubert,
C. Berger,
P. Bochud,
K. Boggian,
T. Calandra,
A. Christe,
A. Conen,
C. Corti-Fragoso,
P. Dutkowski,
P. Eggimann,
C. Garzoni,
D. Goldenberger,
N. Khanna,
F. Lamoth,
O. Marchetti,
E. Maggio,
K. Mühlethaler,
D. Neofytos,
D. Sanglard,
P. Schreiber,
U. Schanz,
C. van Delden,
M. von Kietzell,
R. Zbinden,
S. Zimmerli,
F. A. V. D. A. K. N. T. B. E. E. D. C. E. J. D. S. L. Artru Bignon Coiteux Deblauw El Kalioubie Faure Fr,
F. Artru,
A. Bignon,
V. Coiteux,
D. Deblauw,
A. El Kalioubie,
K. Faure,
N. François,
T. Galpérine,
B. Guery,
E. Jaillette,
Eric Kipnis,
D. Mathieu,
C. Nilès,
E. Parmentier-Decrucq,
J. Poissy,
D. Poulain,
S. Préau,
L. Rahmania,
L. Robriquet,
A. Rouzé,
B. Sendid,
E. Vega,
B. Voisin,
P. Weyrich
|
6 |
2020 |
6
🐜
|
|
🐜
|
Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma
7 auth.
P. Moreau,
V. Coiteux,
C. Hulin,
X. Leleu,
H. V. D. van de Velde,
M. Acharya,
...
J. Harousseau
|
6 |
2008 |
6
🐜
|
|
🐜
|
Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study.
11 auth.
R. Duléry,
J. Salleron,
A. Dewilde,
J. Rossignol,
E. Boyle,
J. Gay,
...
E. de Berranger,
V. Coiteux,
J. Jouet,
A. Duhamel,
I. Yakoub-Agha
|
6 |
2012 |
6
🐜
|
